219 related articles for article (PubMed ID: 32768317)
1. Temporal trend of circulating trans-fatty acids and risk of long-term mortality in general population.
Wang S; Tian W; Liu Y; Yan G; Fang S; Wang Y; Yu B
Clin Nutr; 2021 Mar; 40(3):1095-1101. PubMed ID: 32768317
[TBL] [Abstract][Full Text] [Related]
2. Association between plasma concentrations of elaidic acid, a major trans fatty acid, and depression in a nationally representative sample of U.S. adults.
Liu B; Sun Y; Xu G; Du Y; Ajjarapu AS; Snetselaar LG; Bao W
J Affect Disord; 2019 Apr; 249():301-306. PubMed ID: 30797122
[TBL] [Abstract][Full Text] [Related]
3. Association between plasma trans-fatty acid concentrations and diabetes in a nationally representative sample of US adults.
Liu B; Sun Y; Snetselaar LG; Sun Q; Yang Q; Zhang Z; Liu L; Hu FB; Bao W
J Diabetes; 2018 Aug; 10(8):653-664. PubMed ID: 29446544
[TBL] [Abstract][Full Text] [Related]
4. The association between plasma trans-fatty acids level and migraine: A cross-sectional study from NHANES 1999-2000.
Yao K; Zu HB
Prostaglandins Leukot Essent Fatty Acids; 2024 Feb; 201():102624. PubMed ID: 38865817
[TBL] [Abstract][Full Text] [Related]
5. Plasma
Vesper HW; Caudill SP; Kuiper HC; Yang Q; Ahluwalia N; Lacher DA; Pirkle JL
Am J Clin Nutr; 2017 May; 105(5):1063-1069. PubMed ID: 28381474
[No Abstract] [Full Text] [Related]
6. Association between plasma trans fatty acids concentrations and leucocyte telomere length in US adults.
Mazidi M; Banach M; Kengne AP
Eur J Clin Nutr; 2018 Apr; 72(4):581-586. PubMed ID: 29500463
[TBL] [Abstract][Full Text] [Related]
7. Plasma Industrial and Ruminant Trans Fatty Acids and Incident Type 2 Diabetes in the EPIC-Potsdam Cohort.
Prada M; Wittenbecher C; Eichelmann F; Wernitz A; Kuxhaus O; Kröger J; Weikert C; Schulze MB
Diabetes Care; 2022 Apr; 45(4):845-853. PubMed ID: 35129607
[TBL] [Abstract][Full Text] [Related]
8. Plasma trans-fatty acids levels and mortality: a cohort study based on 1999-2000 National Health and Nutrition Examination Survey (NHANES).
Li H; Zhang Q; Song J; Wang A; Zou Y; Ding L; Wen Y
Lipids Health Dis; 2017 Sep; 16(1):176. PubMed ID: 28915883
[TBL] [Abstract][Full Text] [Related]
9. Trans-fatty acids and mortality in patients referred for coronary angiography: the Ludwigshafen Risk and Cardiovascular Health Study.
Kleber ME; Delgado GE; Lorkowski S; März W; von Schacky C
Eur Heart J; 2016 Apr; 37(13):1072-8. PubMed ID: 26396230
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Ruminant and Industrial 18-Carbon
Valenzuela CA; Baker EJ; De Souza CO; Miles EA; Calder PC
Molecules; 2021 Sep; 26(19):. PubMed ID: 34641380
[TBL] [Abstract][Full Text] [Related]
11. Relationship between plasma trans-fatty acid isomer concentrations and self-reported cardiovascular disease risk in US adults.
Zhang Q; Yang Y; Hu M; Li H; Zhong Q; Huang F
Int J Food Sci Nutr; 2018 Dec; 69(8):976-984. PubMed ID: 29376474
[TBL] [Abstract][Full Text] [Related]
12. Serum Trans Fatty Acids Are Not Associated with Weight Gain or Linear Growth in School-Age Children.
Baylin A; Perng W; Mora-Plazas M; Marin C; Villamor E
J Nutr; 2015 Sep; 145(9):2102-8. PubMed ID: 26180252
[TBL] [Abstract][Full Text] [Related]
13. Food sources of individual plasma phospholipid trans fatty acid isomers: the Cardiovascular Health Study.
Micha R; King IB; Lemaitre RN; Rimm EB; Sacks F; Song X; Siscovick DS; Mozaffarian D
Am J Clin Nutr; 2010 Apr; 91(4):883-93. PubMed ID: 20219966
[TBL] [Abstract][Full Text] [Related]
14. Associations between trans fatty acids and systemic immune-inflammation index: a cross-sectional study.
Zhu XF; Hu YQ; Dai ZC; Li XJ; Zhang J
Lipids Health Dis; 2024 Apr; 23(1):122. PubMed ID: 38678208
[TBL] [Abstract][Full Text] [Related]
15. The Association Between Circulating Trans Fatty Acids and Thyroid Function Measures in U.S. Adults.
Wang X; Jiang F; Chen W; Yuan H; Li Y
Front Endocrinol (Lausanne); 2022; 13():928730. PubMed ID: 35898468
[TBL] [Abstract][Full Text] [Related]
16. Trans-fatty acid blood levels of industrial but not natural origin are associated with cardiovascular risk factors in patients with HFpEF: a secondary analysis of the Aldo-DHF trial.
Lechner K; Bock M; von Schacky C; Scherr J; Lorenz E; Lechner B; Haller B; Krannich A; Halle M; Wachter R; Duvinage A; Edelmann F
Clin Res Cardiol; 2023 Nov; 112(11):1541-1554. PubMed ID: 36640187
[TBL] [Abstract][Full Text] [Related]
17. Serum trans fatty acids, asymmetric dimethylarginine and risk of acute myocardial infarction and mortality in patients with suspected coronary heart disease: a prospective cohort study.
Borgeraas H; Hertel JK; Seifert R; Berge RK; Bohov P; Ueland PM; Nygård O; Hjelmesæth J
Lipids Health Dis; 2016 Feb; 15():38. PubMed ID: 26920731
[TBL] [Abstract][Full Text] [Related]
18. Serum elaidic acid concentration and risk of dementia: The Hisayama Study.
Honda T; Ohara T; Shinohara M; Hata J; Toh R; Yoshida D; Shibata M; Ishida T; Hirakawa Y; Irino Y; Sakata S; Uchida K; Kitazono T; Kanba S; Hirata KI; Ninomiya T
Neurology; 2019 Nov; 93(22):e2053-e2064. PubMed ID: 31645469
[TBL] [Abstract][Full Text] [Related]
19. Plasma phospholipid trans-fatty acids levels, cardiovascular diseases, and total mortality: the cardiovascular health study.
Wang Q; Imamura F; Lemaitre RN; Rimm EB; Wang M; King IB; Song X; Siscovick D; Mozaffarian D
J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25164946
[TBL] [Abstract][Full Text] [Related]
20. Dietary intake of trans fatty acids and breast cancer risk in 9 European countries.
Matta M; Huybrechts I; Biessy C; Casagrande C; Yammine S; Fournier A; Olsen KS; Lukic M; Gram IT; Ardanaz E; Sánchez MJ; Dossus L; Fortner RT; Srour B; Jannasch F; Schulze MB; Amiano P; Agudo A; Colorado-Yohar S; Quirós JR; Tumino R; Panico S; Masala G; Pala V; Sacerdote C; Tjønneland A; Olsen A; Dahm CC; Rosendahl AH; Borgquist S; Wennberg M; Heath AK; Aune D; Schmidt J; Weiderpass E; Chajes V; Gunter MJ; Murphy N
BMC Med; 2021 Mar; 19(1):81. PubMed ID: 33781249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
